KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Free Cash Flow (2016 - 2025)

Exact Sciences (EXAS) has disclosed Free Cash Flow for 16 consecutive years, with $120.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 18.39% to $120.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $356.8 million, a 115.53% increase, with the full-year FY2025 number at $356.8 million, up 115.53% from a year prior.
  • Free Cash Flow was $120.4 million for Q4 2025 at Exact Sciences, down from $190.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $193.6 million in Q4 2022 to a low of -$207.4 million in Q1 2022.
  • A 5-year average of $14.7 million and a median of $13.7 million in 2021 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: crashed 546.38% in 2022, then surged 13727.24% in 2024.
  • Exact Sciences' Free Cash Flow stood at -$6.3 million in 2021, then skyrocketed by 3187.59% to $193.6 million in 2022, then dropped by 18.23% to $158.3 million in 2023, then crashed by 35.74% to $101.7 million in 2024, then grew by 18.39% to $120.4 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Free Cash Flow are $120.4 million (Q4 2025), $190.0 million (Q3 2025), and $46.7 million (Q2 2025).